KLF4 and glioblastoma: This work presents SFRP2 and SOX2 as counteracting inducers of gene expression based glioblastoma subtypes, where SFRP2 suppresses SOX2 via non-canonical WNT signaling, KLF4, PDGFRs, and AKT.